Viewing Study NCT00624351


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-01-10 @ 11:16 PM
Study NCT ID: NCT00624351
Status: COMPLETED
Last Update Posted: 2011-09-12
First Post: 2008-02-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease
Sponsor: UCB Pharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module